A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

May 3, 2023

Primary Completion Date

November 27, 2023

Study Completion Date

December 28, 2023

Conditions
Dermatitis, AtopicPruritus
Interventions
DRUG

ASN008

ASN008 topical gel applied twice daily.

OTHER

ASN008 Matching Vehicle

The ASN008 matching vehicle formulation matches the formulation of each ASN008 topical gel dose, but contains no ASN008.

Trial Locations (27)

10075

TrialSpark Investigative Site 0119, New York

11415

TrialSpark Investigative Site 0115, Kew Gardens

19103

TrialSpark Investigative Site 0122, Philadelphia

23226

TrialSpark Investigative Site 0117, Richmond

28405

TrialSpark Investigative Site 0105, Wilmington

33014

TrialSpark Investigative Site 0103, Miami Lakes

33027

TrialSpark Investigative Site 0129, Miramar

40241

TrialSpark Investigative Site 0112, Louisville

45040

TrialSpark Investigative Site 0125, Mason

46250

TrialSpark Investigative Site 0109, Indianapolis

47129

TrialSpark Investigative Site 0131, Clarksville

48326

TrialSpark Investigative Site 0107, Auburn Hills

54506

TrialSpark Investigative Site 0102, Saint Joseph

70808

TrialSpark Investigative Site 0108, Baton Rouge

71201

TrialSpark Investigative Site 0124, Monroe

71913

TrialSpark Investigative Site 0118, Hot Springs

73170

TrialSpark Investigative Site 0127, Oklahoma City

77056

TrialSpark Investigative Site 0121, Houston

78213

TrialSpark Investigative Site 0114, San Antonio

78229

TrialSpark Investigative Site 0126, San Antonio

78660

TrialSpark Investigative Site 0130, Pflugerville

84663

TrialSpark Investigative Site 0110, Springville

85255

TrialSpark Investigative Site 0106, Scottsdale

90057

TrialSpark Investigative Site 0101, Los Angeles

90212

TrialSpark Investigative Site 0123, Beverly Hills

94538

TrialSpark Investigative Site 0113, Fremont

99202

TrialSpark Investigative Site 0128, Spokane

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Formation Bio

INDUSTRY

NCT05870865 - A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis | Biotech Hunter | Biotech Hunter